Skip to main content
PLOS Genetics logoLink to PLOS Genetics
. 2021 Sep 14;17(9):e1009807. doi: 10.1371/journal.pgen.1009807

The chromatin remodeler Chd1 supports MRX and Exo1 functions in resection of DNA double-strand breaks

Marco Gnugnoli 1, Erika Casari 1, Maria Pia Longhese 1,*
Editor: Sue Jinks-Robertson2
PMCID: PMC8462745  PMID: 34520455

Abstract

Repair of DNA double-strand breaks (DSBs) by homologous recombination (HR) requires that the 5’-terminated DNA strands are resected to generate single-stranded DNA overhangs. This process is initiated by a short-range resection catalyzed by the MRX (Mre11-Rad50-Xrs2) complex, which is followed by a long-range step involving the nucleases Exo1 and Dna2. Here we show that the Saccharomyces cerevisiae ATP-dependent chromatin-remodeling protein Chd1 participates in both short- and long-range resection by promoting MRX and Exo1 association with the DSB ends. Furthermore, Chd1 reduces histone occupancy near the DSB ends and promotes DSB repair by HR. All these functions require Chd1 ATPase activity, supporting a role for Chd1 in the opening of chromatin at the DSB site to facilitate MRX and Exo1 processing activities.

Author summary

DNA double strand breaks (DSBs) are among the most severe types of damage occurring in the genome because their faulty repair can result in chromosome instability, commonly associated with carcinogenesis. Efficient and accurate repair of DSBs relies on several proteins required to process them. However, eukaryotic genomes are compacted into chromatin, which restricts the access to DNA of the enzymes devoted to repair DNA DSBs. To overcome this natural barrier, eukaryotes have evolved chromatin remodeling enzymes that use energy derived from ATP hydrolysis to modulate chromatin structure. Here, we examine the role in DSB repair of the ATP-dependent chromatin remodeler Chd1, which is frequently mutated in prostate cancer. We find that Chd1 is important to repair DNA DSBs by homologous recombination (HR) because it promotes the association with a damaged site of the MRX complex and Exo1, which are necessary to initiate HR. This Chd1 function requires its ATPase activity, suggesting that Chd1 increases the accessibility to chromatin to initiate repair of DNA lesions.

Introduction

DNA double-strand breaks (DSBs) are the most common cause of genomic instability, because their inaccurate repair can lead to chromosomal rearrangements. DSBs can be repaired by either homologous recombination (HR), which uses homologous DNA from sister chromatids or homologous chromosomes as a template for repair, or non-homologous end joining (NHEJ), which directly re-ligates the broken DSB ends [1].

HR is initiated by nucleolytic degradation of the 5’-terminated strands at the DSB ends to generate 3’-ended single stranded DNA (ssDNA), in a process called resection [2]. In both yeast and mammals, DSB resection is initiated by the Mre11-Rad50-Xrs2/NBS1 (MRX/N) complex that, aided by the Sae2 protein (CtIP in mammals), cleaves the 5’-terminated DNA strand on either side of a DSB [3]. This step is followed by 3’-5’ nucleolytic degradation by Mre11, which proceeds back towards the DNA end and by the Exo1 or the Dna2 nuclease, which degrades double-stranded DNA (dsDNA) in the 5’-3’ direction [411]. The resulting 3’-ended ssDNA is first coated by the Replication Protein A (RPA) complex, which is replaced by the Rad51 recombinase, creating a nucleoprotein filament that searches and anneals to a homologous DNA sequence [1]. Repair can then take place via synthesis-dependent strand annealing (SDSA) or the canonical recombination pathway that involves formation of a double Holliday junction [12].

The repair of DNA DSBs is challenged by the packaging of genomic DNA through histone and non-histone proteins into a high-order structure called chromatin, raising the question as to how the DNA repair machineries overcome this barrier to gain access to damaged DNA. The presence of nucleosomes inhibits DSB resection in vitro [13]. Furthermore, a genome-wide analysis of resection endpoints around Spo11-induced DSBs during meiosis showed that resection frequently terminates at nucleosomes, reflecting a tendency for nucleosomes to block nuclease activity in vivo [14]. Chromatin immunoprecipitation experiments support nucleosome disassembly near DSBs [15]. Furthermore, recent data indicate that histones exclusively associate with dsDNA and that the rate of histone loss correlates with resection [16], suggesting that nucleosome eviction occurs concomitantly with DSB resection.

Indeed, chromatin structure is tuned by various processes such as nucleosome remodeling by ATP-dependent chromatin remodelers. These protein complexes use the energy derived from ATP hydrolysis to alter histone-DNA interactions, resulting in nucleosome sliding, eviction, and/or histone exchange [17,18]. Several ATP-dependent nucleosome remodelers have been implicated in HR, particularly with regard to DSB resection [1920]. In budding yeast, the RSC, INO80 and SWI/SNF protein complexes are recruited to chromatin regions adjacent to a nuclease-induced DSB [2124]. Furthermore, their lack reduces not only nucleosome removal/sliding but also DSB resection [21,22,2528], suggesting that nucleosome eviction and resection are intrinsically coupled. These changes in chromatin compaction have been shown to facilitate the access to DSBs of DNA repair proteins, such as MRX, Rad51 and Rad52 [15,21,22,25].

Another chromatin remodeler implicated in DSB resection is Fun30 (SMARCAD1 in mammals), which has highest sequence homology to INO80-like remodelers but lacks the split ATPase domain [2931]. In contrast to INO80 that promotes DSB resection either by removing histones or by controlling distribution of the histone variant H2A.Z adjacent to a DSB [15,21,26,32,33], Fun30 promotes DSB resection by antagonizing the association with DSBs of Rad9 that inhibits the processing activity of Exo1 [2931].

The evolutionary conserved chromodomain-helicase-DNA-binding protein 1 (Chd1) is an ATP-dependent chromatin remodeler that contains a N-terminal tandemly arranged chromodomain and a central ATPase-helicase domain that confers nucleosome spacing, removal or exchange activity [34,35]. In contrast to most chromatin remodelers, Chd1 is active as a monomer and does not assemble as a multi-subunit complex. Chd1 has the ability to assemble histones along dsDNA and to induce a regular nucleosome spacing [3639]. In yeast, Chd1 was shown to associate with RNA polymerase II elongation factors on actively transcribed genes and to be important for recycling histones over coding regions during transcription [4042]. Experiments in yeasts have shown that Chd1 is also important for generating spaced nucleosomes at the 5’ end of several genes [38,4345].

Only one CHD protein is present in yeast (Chd1), whereas at least nine CHD proteins are expressed in vertebrates. Among them, CHD1, CHD2, CHD3, CHD4, CHD6 and CHD7 have been implicated in the cellular response to DNA damage. In particular, CHD2, CHD3, CHD4 and CHD7 accumulate at DNA regions flanking a DSB and promote the recruitment of proteins involved in NHEJ [46], whereas CHD6 is a key component of the signaling and transcriptional response to reactive oxygen species [47].

In humans, CHD1 is one of the most frequently inactivated genes in prostate cancer [4850]. Furthermore, its loss sensitizes prostate cancer cells to chemotherapeutic DNA-damaging agents, suggesting a role in the DNA damage response [51]. Consistent with this hypothesis, CHD1 is recruited to UV-damaged nucleosomes in a manner dependent on the DNA binding protein XPC [52]. Furthermore, it promotes the repair of UV-damaged DNA by stimulating the handover between XPC protein and the TFIIH complex at DNA damaged sites [52]. CHD1 is also recruited to chromatin in response to DSBs, where it promotes the loading of CtIP [53,54]. Furthermore, loss of CHD1 decreases the assembly of RPA and RAD51 foci at DNA breaks and stalled replication forks [53,55], suggesting a role in DSB resection. Finally, in Saccharomyces cerevisiae, Chd1 interacts with Exo1 and participates in the generation of meiotic crossovers by enabling the processing of joint molecules by both Exo1 and the mismatch repair complex Mlh1-Mlh3 (MutLγ) [56].

In this study, we found that Saccharomyces cerevisiae Chd1 improves the efficiency of nucleosome eviction from the DSB ends. Furthermore, it promotes DSB resection by enhancing the association of the MRX complex and Exo1 with the DSB ends. The lack of its ATPase activity impairs all these functions, suggesting that Chd1 promotes MRX and Exo1 resection activities by increasing their accessibility to DSBs.

Results

Chd1 is recruited to a DSB and its lack reduces histone removal

To investigate whether Chd1 has a direct role in the repair of DNA DSBs, we first evaluated whether Chd1 is physically enriched at a DSB by chromatin immunoprecipitation (ChIP). To this end, we used a strain background carrying a galactose-inducible HO endonuclease, which generates a single DSB at the MAT locus in the presence of galactose [57]. To minimize the effect of DSB repair, the MAT homology regions HML and HMR were deleted, leading to a DSB that cannot be repaired by HR [57]. Following HO induction by galactose addition, Chd1-Myc was recruited near the HO-induced DSB and its binding increases over three hours (Fig 1A).

Fig 1. Chd1 recruitment to a DSB and histone removal.

Fig 1

(A) Exponentially growing YEPR cell cultures of JKM139 derivative strains were transferred to YEPRG, followed by Chd1-Myc ChIP at the indicated distances from the HO-cut site compared to untagged Chd1 (no tag). Data are expressed as fold enrichment at the HO-cut site over that at a non-cleavable locus (ARO1), after normalization to the corresponding input for each time point. Fold enrichment was then normalized to cut efficiency. Plotted values are the mean values ± s.d. from three independent experiments. ***P<0.005, **P<0.01, *P<0.05, t-test. (B) HO expression was induced by galactose addition to G2-arrested cells carrying the HO system at the LEU2 or at the MAT locus. Cells were kept arrested in G2 by nocodazole throughout the experiment. Histone H3 ChIP with anti-H3 antibody at the indicated distances from the HO-cut site. Data are expressed as fold enrichment at the HO-cut site over that at the non-cleavable ARO1 locus after normalization to the corresponding input for each time point. Fold enrichment was normalized to cut efficiency. Plotted values are the mean values ± s.d. from three independent experiments.

After a DSB is formed, nucleosomes are rapidly evicted at both sides of the DSB and this process is thought to promote DSB repair by facilitating the access of DNA repair proteins [19,20]. As Chd1 has a nucleosome eviction activity [34], we analyzed occupancy of histone H3 near the HO-induced DSB at both the LEU2 and the MAT loci. To exclude possible effects of DNA replication on histone association with DNA, HO expression was induced by galactose addition to G2-arrested cells that were kept arrested in G2 with nocodazole for the duration of the experiment. Furthermore, to exclude that possible differences in histone occupancy were due to different repair kinetics, repair of the HO-induced DSB at the LEU2 locus was prevented by deleting RAD52, whereas repair of the HO-induced DSB at the MAT locus was prevented by deleting the homologous donor loci HML and HMR. The H3 signal detected near the HO-induced DSB at both the LEU2 and the MAT loci remained higher in chd1Δ than in wild type cells, suggesting that Chd1 participates in histone removal near a DSB (Fig 1B).

Chd1 carries an ATP-binding domain (AAA domain) that contains conserved Walker A and B motifs [58]. Within the P-loop of Walker A, a conserved lysine residue (K407 in Chd1) in the consensus sequence GXXXXGK[T/S] (where X is any amino acid) directly interacts with the phosphates of ATP. Mutation of this residue eliminates both ATP binding and ATPase activity [5961]. The Walker B motif contains aspartate (D513 in Chd1) and glutamate (E514 in Chd1) residues within the hhhhDE sequence (where h represents a hydrophobic amino acid) that are crucial for ATPase activity, with the D residue coordinating Mg2+ and the E residue activating water for the hydrolysis reaction [62]. Mutation of the E residue was shown to impair nucleotide hydrolysis without affecting ATP binding [60,62,63]. To test whether the ATPase activity of Chd1 is required for histone eviction around the DSB, we introduced either the K407R or the E514A amino acid substitution into Chd1. Both chd1-K407R and chd1-E514A mutant cells were as defective in histone removal from the HO-induced DSB as chd1Δ cells (Fig 1B).

Chd1 promotes DSB resection

Nucleosome eviction from DSBs occurs concomitantly with DSB resection [16], prompting us to monitor directly the generation of ssDNA at the HO-induced DSB in chd1Δ, chd1-K407R and chd1-E514A mutant cells. Because ssDNA cannot be cleaved by most restriction enzymes, generation of ssDNA was assessed by testing resistance to cleavage as resection proceeds beyond restriction sites located at different distances from the HO-cut site at the MAT locus (Fig 2A). First, we used a Southern blot analysis approach to detect the appearance of slower migrating bands (r1-r6) after denaturing gel electrophoresis of SspI-digested genomic DNA and hybridization with a probe that anneals to the unresected strand at one side of the DSB (Fig 2B). When HO was induced by galactose addition to exponentially growing cells, the resection products (r2 to r6) appeared less efficiently in galactose-induced chd1Δ, chd1-K407R and chd1-E514A mutant cells compared to wild type cells (Fig 2B and 2C). The resection defect of chd1Δ cells was similar to that of sae2Δ cells, whereas it was less severe than that of mre11Δ cells (S1 Fig).

Fig 2. Chd1 dysfunction reduces DSB resection.

Fig 2

(A) Schematic representation of the MAT locus and the distance of RsaI (R) and SspI (S) restriction sites from the HO-cut site. The DNA fragments detected in panel B before (uncut) and after HO cleavage (HO-cut) were also indicated. (B) YEPR exponentially growing cell cultures of JKM139 derivative strains were transferred to YEPRG at time zero. Southern blot analysis of SspI-digested genomic DNA after alkaline gel electrophoresis with a probe that anneals to the unresected strand. 5’-3’ resection progressively eliminates SspI sites (S), producing SspI fragments (r1 through r6) detected by the probe. (C) The experiment as in panel B has been independently repeated three times, and the mean values are represented with error bars denoting s.d. (D) Quantification of ssDNA by qPCR at the indicated distances from the HO-cut site. Plotted values are the mean values of three independent experiments, with error bars denoting s.d. ***P < 0.005, **P < 0.01, *P < 0.05, t-test. (E) Western blot with anti-Rad51 antibodies of extracts used for the ChIP analysis shown in panel F. The same amount of extracts was separated by SDS-PAGE and stained with Coomassie Blue as loading control. (F) Rad51 ChIP at the indicated distances from the HO-induced DSB. Data are expressed as fold enrichment at the HO-cut site over that at the non-cleavable ARO1 locus, after normalization to the corresponding input for each time point. Fold enrichment was normalized to cut efficiency. Plotted values are the mean values ± s.d. from three independent experiments. ***P<0.005, **P<0.01, *P<0.05, t-test.

Detection of SspI-resistant ssDNA by denaturing gel electrophoresis does not allow one to monitor the resection events that do not proceed beyond the SspI site located 0.9 kb from the HO-induced DSB. Furthermore, the signal for the r1 resection product, which can be detected when resection does not proceed beyond the SspI site located 1.7 kb from the DSB, is very low and difficult to quantify. Thus, we used a quantitative PCR-based method to evaluate generation of restriction enzyme-resistant ssDNA [64]. CHD1 deletion caused a reduction in ssDNA generation very close to the HO-cut site (0.15 kb, 0.65 kb and 0.9 kb) (Fig 2D), indicating a defect in initiation of resection. The same analysis at more distant sites (1.7 kb and 3.5 kb) (Fig 2D) confirmed the long-range resection defect that was detected by denaturing Southern blotting. We can conclude that Chd1 is involved in both short- and long-range resection.

The 3’-ended ssDNA generated during DSB resection is coated by the RPA complex, which is replaced by Rad51 to generate a nucleoprotein filament that invades and anneals to a homologous DNA sequence [1]. Although protein extracts from wild type, chd1Δ, chd1-K407R and chd1-E514A cells contained similar Rad51 amount (Fig 2E), Rad51 association at different distances from the HO-induced DSB was reduced in chd1Δ, chd1-K407R and chd1-E514A cells compared to wild type cells (Fig 2F), consistently with a role of Chd1 in both initiation and extension of DSB resection.

Chd1 promotes MRX and Exo1 association with DSBs

DSB resection involves sequential action of short- and long-range nucleases. In short-range resection, Mre11 endonuclease, aided by Sae2, cleaves the 5’-terminated DNA strand at ~250–300 nucleotides from the DSB ends, followed by degradation toward the DNA ends by Mre11 exonuclease. Then, Exo1 or Dna2 resects thousands of nucleotides in length in the 5’-3’ direction away from the DSB ends [311]. While MRX and Sae2 binding to DSBs occurs independently of each other [65], MRX has a structural role in promoting Exo1 and Dna2 association with DSBs [66], thus explaining the more severe resection defect caused by the lack of any MRX subunit compared to that caused by the lack of Mre11 nuclease activity.

As Chd1 dysfunction leads to a defect in both short- and long-range resection, we measured MRX, Sae2 and Exo1 association with the HO-induced DSB. The amount of Mre11 (Fig 3A) and Exo1 (Fig 3B) bound at the HO-induced DSB was lower in chd1Δ, chd1-K407R and chd1-E514A cells than in wild type cells. The decreased Mre11 and Exo1 recruitment was not due to lower protein levels, as protein extracts prepared from wild type, chd1Δ, chd1-K407R and chd1-E514A cells contained similar amounts of Mre11 (Fig 3C) and Exo1 (Fig 3D). By contrast, Sae2 association with the HO-induced DSB was similar in wild type, chd1Δ, chd1-K407R and chd1-E514A cells (Fig 3E). Thus, we can conclude that Chd1 facilitates MRX and Exo1 association with DSBs.

Fig 3. Chd1 dysfunction impairs MRX and Exo1 association with a DSB.

Fig 3

(A,B) Mre11-Myc (A) and Exo1-Myc (B) ChIP at the indicated distances from the HO-cut site. Data are expressed as fold enrichment at the HO-cut site over that at a non-cleavable locus (ARO1), after normalization to the corresponding input for each time point. Fold enrichment was normalized to cut efficiency. Plotted values are the mean values ± s.d. from three independent experiments. ***P<0.005, **P<0.01, *P<0.05, t-test. (C,D) Western blot with anti-Myc antibodies of extracts used for the ChIP analysis shown in panels A and B. (E) Sae2-Myc ChIP at the indicated distances from the HO-cut site.

Chd1 promotes DSB repair by HR

The finding that Chd1 promotes DSB resection led us to investigate whether Chd1 has a role in HR. Among the HR repair pathways, single-strand annealing (SSA) is used to repair a DSB flanked by direct DNA repeats when resection uncovers the complementary DNA sequences that can then anneal to each other [67]. To measure the efficiency of SSA, we used YMV45 derivative strains that carry the GAL-HO construct and tandem repeats of the LEU2 gene located 4.6 kb apart on chromosome III, with the HO cutting site adjacent to one of the repeats (Fig 4A) [68]. HO was induced by galactose addition to exponentially growing cells and galactose was maintained in the medium in order to re-cleave the HO sites that can be rejoined by NHEJ. When DSB repair was monitored by Southern blot analysis with a LEU2 probe, accumulation of the SSA repair product was delayed in chd1Δ, chd1-K407R and chd1-E514A cells compared to wild type cells (Fig 4B and 4C), indicating a role for Chd1 in the SSA repair mechanism. Consistent with a defective DSB repair by SSA, chd1Δ, chd1-K407R and chd1-E514A cells showed a decreased viability on galactose-containing plates (HO expression on) compared to wild type cells (Fig 4D).

Fig 4. Chd1 dysfunction reduces DSB repair by SSA.

Fig 4

(A) Schematic representation of the YMV45 chromosome III region, where a unique HO-cut site is adjacent to the leu2::cs sequence, which is 4.6 kb apart from the homologous leu2 sequence. HO-induced DSB results in generation of 12 kb and 2.5 kb DNA fragments (HO-cut) that can be detected by Southern blot analysis with a LEU2 probe of KpnI-digested genomic DNA. DSB repair by SSA generates a product of 8 kb (SSA). K, KpnI. (B) Exponentially growing YEPR cell cultures of YMV45 derivative strains were transferred to YEPRG. Southern blot analysis of KpnI-digested genomic DNA. (C) Densitometric analysis of the SSA product. Plotted values are the mean values of three independent experiments as in panel B, with error bars denoting s.d. (D) Percentage of colony formation on YEPRG plates relatives to colony formation on YEPD plates. The reported values are the mean values of three independent experiments, with error bars denoting s.d. ***P<0.005, t-test.

Because the SSA repair mechanism does not require strand invasion and therefore does not involve the Rad51 protein [69], we investigated the role of Chd1 in the generation of Rad51-dependent crossover (CO) and non-crossover (NCO) events by ectopic recombination. In the canonical HR pathway, ssDNA invades the homologous dsDNA to form a D-loop structure consisting of heteroduplex DNA and displaced ssDNA. If the displaced ssDNA anneals with the complementary sequence on the other side of the break, extension by DNA synthesis and ligation result in the formation of a double Holliday junction, whose cleavage results in equal number of NCO and CO products. However, if the invading strand extended by DNA synthesis is displaced and anneals with the complementary sequences on the other side of the DSB, this event leads to NCO products by SDSA [70,71].

To analyze formation of CO and NCO products, we used tGI354 derivative strains that carry two copies of the MATa sequence [72]. One copy carries the HO cutting site and is located ectopically on chromosome V, whereas the endogenous MAT sequence on chromosome III carries a single base pair mutation that prevents cleavage by HO (MATa-inc) (Fig 5A). The HO-induced DSB at the MAT sequence on chromosome V can be repaired by using the uncleaved MATa-inc sequence on chromosome III, resulting in CO and NCO products (Fig 5A) [72,73]. HO was induced by galactose addition to G2-arrested cells and galactose was maintained in the medium to cleave the HO sites that were eventually reconstituted by NHEJ. Both the 3 kb and the 3.4 kb band resulting from NCO and CO recombination events, respectively, accumulated less efficiently in chd1Δ and chd1-E514A cells compared to wild type cells, with the NCO band decreasing more severely than the CO band (Fig 5B and 5C), indicating a role for Chd1 in Rad51-dependent HR.

Fig 5. Chd1 dysfunction reduces DSB repair by HR.

Fig 5

(A) System to detect ectopic recombination. HO generates a DSB at a MATa DNA sequence inserted on chromosome V, while the homologous MATa-inc region on chromosome III cannot be cut by HO and is used as a donor to generate noncrossover (NCO) and crossover (CO) products. E, EcoRI. (B) G2-arrested YEPR cell cultures of tGI354 derivative strains were transferred to YEPRG at time zero and were kept arrested in G2 by nocodazole. Southern blot analysis of EcoRI-digested genomic DNA with the MATa probe depicted in panel A. (C) Densitometric analysis of CO (3.4 kb) versus NCO (3 kb) repair bands at the indicated times after HO induction. (D) Percentage of colony formation on YEPRG plates relatives to colony formation on YEPD plates. Plotted values are the mean values of three independent experiments, with error bars denoting s.d. ***P<0.005, t-test. (E) Plasmid re-ligation assay. Cells were transformed with the same amounts of BamHI-linearized pRS316 plasmid DNA. Data are expressed as percentage of re-ligation relative to wild type that was set up at 100% after normalization to the corresponding transformation efficiency. (F) Ku70-HA ChIP at the indicated distance from the HO-cut site.

Consistent with defective DSB repair by ectopic recombination, a lower percentage of chd1Δ and chd1-E514A cells were able to form colonies on galactose-containing plates compared to wild type cells (Fig 5D).

The role of Chd1 in supporting DSB repair appears to be restricted to HR-based mechanisms. In fact, when we measured the ability of cells to re-ligate by NHEJ a plasmid that was linearized before being transformed into the cells, the efficiency of plasmid re-ligation was similar in wild type, chd1Δ and chd1-E514A cells (Fig 5E). Furthermore, the amount of Ku70 bound at the HO-induced DSB in both chd1Δ and chd1-E514A cells was similar to that of wild type cells (Fig 5F).

Chd1 supports DNA damage resistance and long-range resection when MRX is not fully functional

The rad50-V1269M (rad50-VM) mutation leads to a decreased MRVMX association with DSBs [74]. To investigate whether the diminished MRX binding to DSBs in chd1Δ cells is physiologically important, we analyzed the effect of Chd1 dysfunction in rad50-VM cells. CHD1 deletion and the presence of chd1-K407R or chd1-E514A allele, which caused by themselves a mild sensitivity to high doses of phleomycin (phleo), camptothecin (CPT) or methyl methanesulfonate (MMS) (S2 Fig), exacerbated the sensitivity to genotoxic agents of rad50-VM cells (Fig 6A).

Fig 6. Chd1 dysfunction exacerbates the DNA damage sensitivity and the long-range resection defect of rad50-VM cells.

Fig 6

(A) Exponentially growing cultures were serially diluted (1:10) and each dilution was spotted out onto YEPD plates with or without CPT or MMS. (B) Mre11-Myc ChIP at the indicated distances from the HO cleavage site. Data are expressed as fold enrichment at the HO-cut site over that at a non-cleavable locus (ARO1), after normalization to the corresponding input for each time point. Fold enrichment was normalized to cut efficiency. Plotted values are the mean values ± s.d. from three independent experiments. ***P<0.005, **P<0.01, *P<0.05, t-test. (C) Western blot with anti-Myc antibodies of extracts used for the ChIP analysis shown in panel B. (D) Quantification of ssDNA by qPCR at different distances from the HO-cut site. Plotted values are the mean values of three independent experiments, with error bars denoting s.d. ***P<0.005, **P<0.01, *P<0.05, t-test. (E) Exponentially growing cultures were serially diluted (1:10) and each dilution was spotted out onto YEPD plates with or without CPT. (F,G) Percentage of colony formation of YMV45 (F) and tGI354 (G) derivative strains on YEPRG plates relative to colony formation on YEPD plates. Plotted values are the mean values of three independent experiments, with error bars denoting s.d. *P<0.05, t-test.

As previously reported [74], rad50-VM cells slightly decreased Mre11 association with the HO-induced DSB (Fig 6B). Although similar amount of Mre11 can be detected in protein extracts from wild type, chd1Δ, rad50-VM and chd1Δ rad50-VM cells (Fig 6C), the amount of Mre11 bound to the HO-induced DSB was lower in chd1Δ rad50-VM cells than in chd1Δ and rad50-VM cells (Fig 6B), thus explaining the increased DNA damage sensitivity of chd1Δ rad50-VM double mutant cells.

We also monitored the resection kinetics by following resistance to cleavage by restriction enzymes at different distances from the HO-induced DSB. As previously reported [74], the rad50-VM mutation affected DSB resection only very mildly (Fig 6D). ssDNA generation close to the HO-cut site (0.15 kb and 0.65 kb) in chd1Δ rad50-VM cells was similar to that of chd1Δ cells (Fig 6D). By contrast, chd1Δ rad50-VM cells showed a reduction in ssDNA generation at more distant sites (1.7 kb, 3.5 kb, 6.5 kb and 8.9 kb) compared to both chd1Δ and rad50-VM cells (Fig 6D), indicating a more severe long-range resection defect in the double mutant. Consistent with a role of Chd1 in promoting extended DSB processing, the DNA damage sensitivity of both chd1Δ and chd1Δ rad50-VM cells was partially suppressed by EXO1 overexpression (Fig 6E), indicating that part of their DNA damage sensitivity was due to defects in DNA processing.

While DSB repair by SSA requires that resection reaches the complementary DNA sequences that can anneal to each other, DSB repair by ectopic recombination does not require extensive processing of the DSB ends [7577]. Consistent with the finding that chd1Δ rad50-VM cells compromised extended DSB resection more severely than chd1Δ cells, percentage of survival of chd1Δ rad50-VM cells was lower than that of chd1Δ cells upon generation of a HO-induced DSB that is repaired by SSA (Fig 6F). By contrast, chd1Δ and chd1Δ rad50-VM cells showed similar percentage of survival upon generation of a HO-induced DSB that is repaired by ectopic recombination (Fig 6G).

Discussion

In mammals, loss of the ATP-dependent chromatin-remodeling protein CHD1 impairs DSB repair and decreases the assembly of RPA and RAD51 foci [51], suggesting a role for this protein in DSB resection. This study shows that the lack of S. cerevisiae Chd1 reduces nucleosome eviction from the DSB ends. Furthermore, its lack impairs both short- and long-range resection by reducing MRX and Exo1 association with DSBs. The Chd1 functions in nucleosome eviction from DSBs and resection require its ATPase activity, suggesting that Chd1 promotes resection by acting as nucleosome evictor in the opening of chromatin to promote/stabilize MRX and Exo1 association with DSBs. Consistent with a role of chromatin compaction in counteracting MRX and Exo1 accessibility to the DSB ends, assembly of DNA into nucleosomes causes inhibition of both Exo1 resection activity and MRX-dependent activation of Tel1 kinase [13,78]. Furthermore, high-throughput single-molecule microscopy has shown that MRN searches for free DNA ends by one-dimensional facilitated diffusion and transiently dissociates from the DNA backbone to bypass a nucleosome [79].

The decreased DSB resection in chd1 mutants impairs DSB repair by SSA, which requires that resection of the DSB ends reaches the complementary DNA sequences. Furthermore, the lack of Chd1 or of its ATPase activity leads to a reduction of NCO products during ectopic recombination. Consistent with a previous finding that the lack of Chd1 does not affect formation of ectopic CO products in mitotically dividing cells [56], the generation of CO products in chd1 mutants is only slightly affected. In any case, the role of Chd1 appears specific for DSB repair by HR, as the lack of Chd1 affects neither DSB repair by NHEJ nor the association of the Ku complex with DSBs.

The function of Chd1 in promoting MRX binding/persistence to DSBs becomes important to support DNA damage resistance when MRX accumulation at DSBs is suboptimal, such as in the presence of the rad50-VM mutation. This mutation reduces MRX association with DSBs and the lack of Chd1 reduces further the amount of MRVMX bound to DSBs. As a consequence, chd1Δ rad50-VM cells are more sensitive to genotoxic agents compared to each single mutant. Interestingly, while resection very close to the DSB occurs with similar kinetics in chd1Δ and chd1Δ rad50-VM cells, long-range resection is compromised more severely in chd1Δ rad50-VM cells compared to both chd1Δ and rad50-VM single mutants. These findings, together with the observation that overexpression of EXO1, which is the main nuclease involved in long-range resection, partially suppresses the DNA damage sensitivity of both chd1Δ and chd1Δ rad50-VM cells, suggests a direct role of Chd1 in supporting Exo1 resection activity. In accord with this hypothesis, Chd1 was found to interact with Exo1 and to enable MutLγ-Exo1-dependent processing of joint molecules into COs during meiosis I [56].

While in mammals CHD1 was shown to promote the recruitment of CtIP to DSBs, the association of Sae2, the yeast CtIP counterpart, does not require Chd1 function. However, it should be pointed out that the localization of CtIP to DSBs in both mammals and S. pombe requires the MRN complex [8082], whereas Sae2 association with DSBs in S. cerevisiae occurs independently of MRX [65]. As the role of mammalian CHD1 in promoting MRN association with DSBs has not been investigated yet, one possibility is that the poor CtIP binding to DSBs in CHD1-depleted cells might be due to a diminished MRN association with DSBs.

In conclusion, we propose that Chd1 increases the accessibility of chromatin to facilitate/stabilize the association of MRX and Exo1 with DSBs, which in turn initiate DSB processing. The CHD1 gene is frequently mutated in prostate cancer where these mutations are associated with a poor prognosis [4851]. Our finding that Mre11 dysfunction can be rendered synthetically lethal with chd1 mutations in the presence of genotoxic agents suggests that MRX inhibitors in combination with DNA-damaging chemotherapy could be beneficial in patients whose tumors are defective in CHD1 function.

Materials and methods

Yeast strains and media

Strain genotypes are listed in S1 Table. Strains JKM139, YMV45 and tGI354, used to detect DSB resection, DSB repair by SSA and DSB repair by ectopic recombination, respectively, were kindly provided by J. Haber (Brandeis University, Waltham, USA). Cells were grown in YEP medium (1% yeast extract, 2% bactopeptone) supplemented with 2% glucose (YEPD), 2% raffinose (YEPR) or 2% raffinose and 3% galactose (YEPRG). Gene disruptions were generated by one-step PCR homology cassette amplification and standard yeast transformation method.

Spot and DSB survival assays

For spot assays, exponentially growing cell cultures were diluted to 1x107 cells/ml. 10-fold serial dilutions were spotted on YEPD with or without the indicated DNA damaging drugs. Plates were incubated for 3 days at 30°C. To determine viability in DSB assays, cells exponentially growing in YEPR were plated onto YEPD and YEPRG plates. Survivor colonies were counted after 3 days of incubation at 30°C, and the survivor percentage was calculated by normalizing colony number on YPRG to colony number on YEPD.

DSB resection at the MAT locus

DSB end resection at the MAT locus in JKM139 derivative strains was analyzed on alkaline agarose gels by using a single-stranded probe that anneals to the unresected DSB strand, as previously described [83]. Quantification of DSB resection was determined by calculating the ratio of band intensities for ssDNA to the total amount of DSB products. To normalize to cut efficiency, the value of the uncut band was subtracted from the total amount of DSB products for each time point. Quantitative PCR (qPCR) analysis of DSB resection at the MAT locus in JKM139 derivative strains was carried out as previously described [64]. Genomic DNA was extracted at different time points following HO induction. Oligonucleotides were designed to detect ssDNA at specific distances from the DSB (0.15 kb, 0.65 kb, 0.9 kb, 1.7 kb, 3.5 kb, 6.5 kb and 8.9 kb) (S2 Table). The DNA was digested with both SspI and RsaI restriction enzymes. A mock reaction without the restriction enzymes was set up in parallel. qPCR was performed on both digested and mock samples using SsoFast EvaGreen supermix (Bio-Rad) on the Bio-Rad CFX Connect Real-Time System apparatus. For each time point, Ct values were normalized to those obtained from the mock sample, and then further normalized to values obtained from an amplicon in the KCC4 control gene. Finally, the obtained values were normalized to the HO-cut efficiency measured by qPCR by using oligonucleotides that anneal on opposite sides with respect to the HO cutting sequence (S2 Table). The percentage of HO-cut was calculated by comparing the Ct values before and after HO induction in undigested samples.

DSB repair by SSA

DSB repair by SSA in YMV45 strains was detected by Southern blot analysis using an Asp718-SalI fragment containing part of the LEU2 gene as a probe, as previously described [84]. Quantitative analysis of DSB repair by SSA was determined by calculating the ratio of band intensities for SSA to the total amount of SSA and DSB products for each time point. To normalize to cut efficiency, the value of the uncut band was subtracted from the total amount of SSA and DSB products.

DSB repair by ectopic recombination

DSB repair by ectopic recombination was detected in tGI354 background as previously described [84]. To determine the repair efficiency, the intensity of the uncut band at 2 h after HO induction (maximum efficiency of DSB formation) was subtracted from the normalized values of NCO and CO bands at the subsequent time points after galactose addition. The obtained values were divided by the normalized intensity of the uncut MATa band at time zero before HO induction (100%).

Chromatin immunoprecipitation and qPCR

ChIP analysis was performed with anti-HA (12CA5), anti-Myc (9E10), anti-H3 (ab1791, Abcam) and anti-Rad51 (ab63798, Abcam) antibodies as previously described [74]. Quantification of immunoprecipitated DNA was achieved by qPCR on a Bio-Rad CFX Connect Real-Time System apparatus. Triplicate samples in 20 μl reaction mixture containing 10 ng of template DNA, 300 nM for each primer, 2X SsoFast EvaGreen supermix (1725201, Bio-Rad) (2X reaction buffer with dNTPs, Sso7d-fusion polymerase, MgCl2, EvaGreen dye, and stabilizers) were run in white 96-well PCR plates Multiplate (MLL9651, Bio-Rad). The qPCR program was as follows: step 1, 98°C for 2 min; step 2, 90°C for 5 s; step 3, 60°C for 15 s; step 4, return to step 2 and repeat 45 times. At the end of the cycling program, a melting program (from 65°C to 95°C with a 0.5°C increment every 5 s) was run to test the specificity of each qPCR. For each time point, data are expressed as fold enrichment at the HO-cut site over that at the non-cleaved ARO1 locus, after normalization of each ChIP signals to the corresponding input signals. Fold enrichment was normalized to cut efficiency that was determined by qPCR. For histone loss, log2 values of the relative enrichment were calculated. Oligonucleotides used for qPCR analyses are listed in S2 Table.

Plasmid religation

The centromeric pRS316 plasmid was digested with the BamHI restriction enzyme before being transformed into the cells. Parallel transformation with undigested pRS316 DNA was used to determine the transformation efficiency. Efficiency of re-ligation was determined by counting the number of colonies grown on medium selective for the plasmid marker and normalizing them with respect to the transformation efficiency for each sample. The re-ligation efficiency in mutant cells was compared to that of wild type cells that was set up to 100%.

Western blotting

Protein extracts for western blot analysis were prepared by trichloroacetic acid (TCA) precipitation. Frozen cell pellets were resuspended in 200 μL 20% TCA. After the addition of acid-washed glass beads, the samples were vortexed for 10 min. The beads were washed with 200 μL of 5% TCA twice, and the extract was collected in a new tube. The crude extract was precipitated by centrifugation at 3000 rpm for 10 min. TCA was discarded and samples were resuspended in 70 μL 6X Laemmli buffer (60mM Tris pH 6.8, 2% SDS, 10% glycerol, 100mM DTT, 0.2% bromophenol blue) containing 0.9% 2-mercaptoethanol and 30 μL 1M Tris pH8.0. Prior to loading, samples were boiled at 95°C and centrifuged at 3.000 rpm for 10 min. To detect Mre11-Myc, Exo1-Myc and Rad51, TCA protein extracts were separated on 10% polyacrylamide gels and probed with anti-Myc (9E10) or anti-Rad51 (ab63798, Abcam) antibody.

Supporting information

S1 Table. List of yeast strains used in this study.

(DOCX)

S2 Table. List of oligonucleotides used in this study.

(DOCX)

S1 Fig. DSB resection.

YEPR exponentially growing cell cultures of JKM139 derivative strains were transferred to YEPRG at time zero. Southern blot analysis of SspI-digested genomic DNA after alkaline gel electrophoresis with a probe that anneals to the unresected strand. 5’-3’ resection progressively eliminates SspI sites (S), producing SspI fragments (r1 through r6) detected by the probe.

(TIF)

S2 Fig. DNA damage sensitivity of chd1 mutants.

Exponentially growing cultures were serially diluted (1:10) and each dilution was spotted out onto YEPD plates with or without CPT, MMS or phleomycin.

(TIF)

S1 Data. Original data sheets.

(XLSX)

Acknowledgments

We thank J. Haber for yeast strains and S. Ratti for preliminary data.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This work was supported by Fondazione AIRC under IG 2017 - ID. 19783 and Progetti di Ricerca di Interesse Nazionale (PRIN) 2017 to M.P.L. E.C. was supported by the Italian Ministry of University and Research (MIUR) through grant “Dipartimenti di Eccellenza-2017” to University of Milano Bicocca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Kowalczykowski SC. An overview of the molecular mechanisms of recombinational DNA repair. Cold Spring Harb Perspect Biol. 2015;7: a016410. doi: 10.1101/cshperspect.a016410 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Casari E, Rinaldi C, Marsella A, Gnugnoli M, Colombo CV, Bonetti D, et al. Processing of DNA double-strand breaks by the MRX complex in a chromatin context. Front Mol Biosci. 2019;6: 43. doi: 10.3389/fmolb.2019.00043 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Cannavo E, Cejka P. Sae2 promotes dsDNA endonuclease activity within Mre11-Rad50-Xrs2 to resect DNA breaks. Nature. 2014;514: 122–125. doi: 10.1038/nature13771 [DOI] [PubMed] [Google Scholar]
  • 4.Mimitou EP, Symington LS. Sae2, Exo1 and Sgs1 collaborate in DNA double-strand break processing. Nature. 2008;455: 770–774. doi: 10.1038/nature07312 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Zhu Z, Chung WH, Shim EY, Lee SE, Ira G. Sgs1 helicase and two nucleases Dna2 and Exo1 resect DNA double-strand break ends. Cell. 2008;134: 981–994. doi: 10.1016/j.cell.2008.08.037 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Cejka P, Cannavo E, Polaczek P, Masuda-Sasa T, Pokharel S, Campbell JL, et al. DNA end resection by Dna2-Sgs1-RPA and its stimulation by Top3-Rmi1 and Mre11-Rad50-Xrs2. Nature. 2010;467: 112–116. doi: 10.1038/nature09355 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Niu H, Chung WH, Zhu Z, Kwon Y, Zhao W, Chi P, et al. Mechanism of the ATP-dependent DNA end-resection machinery from Saccharomyces cerevisiae. Nature. 2010;467: 108–111. doi: 10.1038/nature09318 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Garcia V, Phelps SE, Gray S, Neale MJ. Bidirectional resection of DNA double-strand breaks by Mre11 and Exo1. Nature. 2011;479: 241–244. doi: 10.1038/nature10515 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Shibata A, Moiani D, Arvai AS, Perry J, Harding SM, Genois MM, et al. DNA double-strand break repair pathway choice is directed by distinct MRE11 nuclease activities. Mol Cell. 2014;53: 7–18. doi: 10.1016/j.molcel.2013.11.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Reginato G, Cannavo E, Cejka P. Physiological protein blocks direct the Mre11-Rad50-Xrs2 and Sae2 nuclease complex to initiate DNA end resection. Genes Dev. 2017;31: 2325–2330. doi: 10.1101/gad.308254.117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Wang W, Daley JM, Kwon Y, Krasner DS, Sung P. Plasticity of the Mre11-Rad50-Xrs2-Sae2 nuclease ensemble in the processing of DNA-bound obstacles. Genes Dev. 2017;31: 2331–2336. doi: 10.1101/gad.307900.117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Mehta A, Haber JE. Sources of DNA double-strand breaks and models of recombinational DNA repair. Cold Spring Harb Perspect Biol. 2014;6: a016428. doi: 10.1101/cshperspect.a016428 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Adkins NL, Niu H, Sung P, Peterson CL. Nucleosome dynamics regulates DNA processing. Nat Struct Mol Biol. 2013;20: 836–842. doi: 10.1038/nsmb.2585 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Mimitou EP, Yamada S, Keeney S. A global view of meiotic double-strand break end resection. Science. 2017;355: 40–45. doi: 10.1126/science.aak9704 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Tsukuda T, Fleming AB, Nickoloff JA, Osley MA. Chromatin remodelling at a DNA double-strand break site in Saccharomyces cerevisiae. Nature. 2005;438: 379–383. doi: 10.1038/nature04148 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Peritore M, Reusswig KU, Bantele SCS, Straub T, Pfander B. Strand-specific ChIP-seq at DNA breaks distinguishes ssDNA versus dsDNA binding and refutes single-stranded nucleosomes. Mol Cell. 2021;81: 1841–1853.e4. doi: 10.1016/j.molcel.2021.02.005 [DOI] [PubMed] [Google Scholar]
  • 17.Narlikar GJ, Sundaramoorthy R, Owen-Hughes T. Mechanisms and functions of ATP-dependent chromatin-remodeling enzymes. Cell. 2013;154: 490–503. doi: 10.1016/j.cell.2013.07.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Clapier CR, Iwasa J, Cairns BR, Peterson CL. Mechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes. Nat Rev Mol Cell Biol. 2017;18: 407–422. doi: 10.1038/nrm.2017.26 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Chambers AL, Downs JA. The RSC and INO80 chromatin-remodeling complexes in DNA double-strand break repair. Prog Mol Biol Transl Sci. 2012;110: 229–261. doi: 10.1016/B978-0-12-387665-2.00009-2 [DOI] [PubMed] [Google Scholar]
  • 20.Seeber A, Hauer M, Gasser SM. Nucleosome remodelers in double-strand break repair. Curr Opin Genet Dev. 2013;23: 174–184. doi: 10.1016/j.gde.2012.12.008 [DOI] [PubMed] [Google Scholar]
  • 21.van Attikum H, Fritsch O, Hohn B, Gasser SM. Recruitment of the INO80 complex by H2A phosphorylation links ATP-dependent chromatin remodeling with DNA double-strand break repair. Cell. 2004;119: 777–788. doi: 10.1016/j.cell.2004.11.033 [DOI] [PubMed] [Google Scholar]
  • 22.Chai B, Huang J, Cairns BR, Laurent BC. Distinct roles for the RSC and Swi/Snf ATP-dependent chromatin remodelers in DNA double-strand break repair. Genes Dev. 2005;19: 1656–1661. doi: 10.1101/gad.1273105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Shim EY, Ma JL, Oum JH, Yanez Y, Lee SE. The yeast chromatin remodeler RSC complex facilitates end joining repair of DNA double-strand breaks. Mol Cell Biol. 2005;25: 3934–3944. doi: 10.1128/MCB.25.10.3934-3944.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Bennett G, Peterson CL. SWI/SNF recruitment to a DNA double-strand break by the NuA4 and Gcn5 histone acetyltransferases. DNA Repair (Amst). 2015;30: 38–45. doi: 10.1016/j.dnarep.2015.03.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Shim EY, Hong SJ, Oum JH, Yanez Y, Zhang Y, Lee SE. RSC mobilizes nucleosomes to improve accessibility of repair machinery to the damaged chromatin. Mol Cell Biol. 2007;27: 1602–1613. doi: 10.1128/MCB.01956-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.van Attikum H, Fritsch O, Gasser SM. Distinct roles for SWR1 and INO80 chromatin remodeling complexes at chromosomal double-strand breaks. EMBO J. 2007;26: 4113–4125. doi: 10.1038/sj.emboj.7601835 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Chambers AL, Brownlee PM, Durley SC, Beacham T, Kent NA, Downs JA. The two different isoforms of the RSC chromatin remodeling complex play distinct roles in DNA damage responses. PLoS One. 2012;7: e32016. doi: 10.1371/journal.pone.0032016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Wiest NE, Houghtaling S, Sanchez JC, Tomkinson AE, Osley MA. The SWI/SNF ATP-dependent nucleosome remodeler promotes resection initiation at a DNA double-strand break in yeast. Nucleic Acids Res. 2017;45: 5887–5900. doi: 10.1093/nar/gkx221 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Chen X, Cui D, Papusha A, Zhang X, Chu CD, Tang J, et al. The Fun30 nucleosome remodeller promotes resection of DNA double-strand break ends. Nature. 2012;489: 576–580. doi: 10.1038/nature11355 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Costelloe T, Louge R, Tomimatsu N, Mukherjee B, Martini E, Khadaroo B, et al. The yeast Fun30 and human SMARCAD1 chromatin remodellers promote DNA end resection. Nature. 2012;489: 581–584. doi: 10.1038/nature11353 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Eapen VV, Sugawara N, Tsabar M, Wu WH, Haber JE. The Saccharomyces cerevisiae chromatin remodeler Fun30 regulates DNA end resection and checkpoint deactivation. Mol Cell Biol. 2012;32: 4727–4740. doi: 10.1128/MCB.00566-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Papamichos-Chronakis M, Watanabe S, Rando OJ, Peterson CL. Global regulation of H2A.Z localization by the INO80 chromatin-remodeling enzyme is essential for genome integrity. Cell. 2011;144: 200–213. doi: 10.1016/j.cell.2010.12.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Alatwi HE, Downs JA. Removal of H2A.Z by INO80 promotes homologous recombination. EMBO Rep. 2015;16: 986–994. doi: 10.15252/embr.201540330 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Farnung L, Vos SM, Wigge C, Cramer P. Nucleosome-Chd1 structure and implications for chromatin remodelling. Nature. 2017;550: 539–542. doi: 10.1038/nature24046 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Smolle MM. Chd1 bends over backward to remodel. Nat Struct Mol Biol. 2018;25: 2–3. doi: 10.1038/s41594-017-0014-4 [DOI] [PubMed] [Google Scholar]
  • 36.Simic R, Lindstrom DL, Tran HG, Roinick KL, Costa PJ, Johnson AD, et al. Chromatin remodeling protein Chd1 interacts with transcription elongation factors and localizes to transcribed genes. EMBO J. 2003;22: 1846–1856. doi: 10.1093/emboj/cdg179 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Lusser A, Urwin DL, Kadonaga JT. Distinct activities of CHD1 and ACF in ATP-dependent chromatin assembly. Nat Struct Mol Biol. 2005;12: 160–166. doi: 10.1038/nsmb884 [DOI] [PubMed] [Google Scholar]
  • 38.Gkikopoulos T, Schofield P, Singh V, Pinskaya M, Mellor J, Smolle M, et al. A role for Snf2-related nucleosome-spacing enzymes in genome-wide nucleosome organization. Science. 2011;333: 1758–1760. doi: 10.1126/science.1206097 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Lieleg C, Ketterer P, Nuebler J, Ludwigsen J, Gerland U, Dietz H, et al. Nucleosome spacing generated by ISWI and CHD1 remodelers is constant regardless of nucleosome density. Mol Cell Biol. 2015;35: 1588–1605. doi: 10.1128/MCB.01070-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Radman-Livaja M, Quan TK, Valenzuela L, Armstrong JA, van Welsem T, Kim T, et al. A key role for Chd1 in histone H3 dynamics at the 3’ ends of long genes in yeast. PLoS Genet. 2012;8: e1002811. doi: 10.1371/journal.pgen.1002811 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Smolle M, Venkatesh S, Gogol MM, Li H, Zhang Y, Florens L, et al. Chromatin remodelers Isw1 and Chd1 maintain chromatin structure during transcription by preventing histone exchange. Nat Struct Mol Biol. 2012;19: 884–892. doi: 10.1038/nsmb.2312 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Lee Y, Park D, Iyer VR. The ATP-dependent chromatin remodeler Chd1 is recruited by transcription elongation factors and maintains H3K4me3/H3K36me3 domains at actively transcribed and spliced genes. Nucleic Acids Res. 2017;45: 8646. doi: 10.1093/nar/gkx636 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Hennig BP, Bendrin K, Zhou Y, Fischer T. Chd1 chromatin remodelers maintain nucleosome organization and repress cryptic transcription. EMBO Rep. 2012;13: 997–1003. doi: 10.1038/embor.2012.146 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Pointner J, Persson J, Prasad P, Norman-Axelsson U, Strålfors A, Khorosjutina O, et al. CHD1 remodelers regulate nucleosome spacing in vitro and align nucleosomal arrays over gene coding regions in S. pombe. EMBO J. 2012;31: 4388–4403. doi: 10.1038/emboj.2012.289 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Shim YS, Choi Y, Kang K, Cho K, Oh S, Lee J, et al. Hrp3 controls nucleosome positioning to suppress non-coding transcription in eu- and heterochromatin. EMBO J. 2012;31: 4375–4387. doi: 10.1038/emboj.2012.267 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Rother MB, van Attikum H. DNA repair goes hip-hop: SMARCA and CHD chromatin remodellers join the break dance. Philos Trans R Soc Lond B Biol Sci. 2017;372: 20160285. doi: 10.1098/rstb.2016.0285 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Moore S, Berger ND, Luijsterburg MS, Piett CG, Stanley FKT, Schräder CU, et al. The CHD6 chromatin remodeler is an oxidative DNA damage response factor. Nat Commun. 2019;10: 241. doi: 10.1038/s41467-018-08111-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Burkhardt L, Fuchs S, Krohn A, Masser S, Mader M, Kluth M, et al. CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer. Cancer Res. 2013;73: 2795–2805. doi: 10.1158/0008-5472.CAN-12-1342 [DOI] [PubMed] [Google Scholar]
  • 49.Grasso CS, Wu YM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature. 2012;487: 239–243. doi: 10.1038/nature11125 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Huang S, Gulzar ZG, Salari K, Lapointe J, Brooks JD, Pollack JR. Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness. Oncogene. 2012;31: 4164–4170. doi: 10.1038/onc.2011.590 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Shenoy TR, Boysen G, Wang MY, Xu QZ, Guo W, Koh FM, et al. CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair. Ann Oncol. 2017;28: 1495–1507. doi: 10.1093/annonc/mdx165 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Rüthemann P, Balbo Pogliano C, Codilupi T, Garajovà Z, Naegeli H. Chromatin remodeler CHD1 promotes XPC-to-TFIIH handover of nucleosomal UV lesions in nucleotide excision repair. EMBO J. 2017;36: 3372–3386. doi: 10.15252/embj.201695742 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Kari V, Mansour WY, Raul SK, Baumgart SJ, Mund A, Grade M, et al. Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness. EMBO Rep. 2016;17: 1609–1623. doi: 10.15252/embr.201642352 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Zhou J, Li J, Serafim RB, Ketchum S, Ferreira CG, Liu JC, et al. Human CHD1 is required for early DNA-damage signaling and is uniquely regulated by its N terminus. Nucleic Acids Res. 2018;46: 3891–3905. doi: 10.1093/nar/gky128 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Delamarre A, Barthe A, de la Roche Saint-André C, Luciano P, Forey R, Padioleau I, et al. MRX increases chromatin accessibility at stalled replication forks to promote nascent DNA resection and cohesin loading. Mol Cell. 2020;77: 395–410.e3. doi: 10.1016/j.molcel.2019.10.029 [DOI] [PubMed] [Google Scholar]
  • 56.Wild P, Susperregui A, Piazza I, Dörig C, Oke A, Arter M, et al. Network rewiring of homologous recombination enzymes during mitotic proliferation and meiosis. Mol Cell. 2019;75: 859–874.e4. doi: 10.1016/j.molcel.2019.06.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Lee SE, Moore JK, Holmes A, Umezu K, Kolodner RD, Haber JE. Saccharomyces Ku70, Mre11/Rad50 and RPA proteins regulate adaptation to G2/M arrest after DNA damage. Cell. 1998;94: 399–409. doi: 10.1016/s0092-8674(00)81482-8 [DOI] [PubMed] [Google Scholar]
  • 58.Hanson PI, Whiteheart SW. AAA+ proteins: have engine, will work. Nat Rev Mol Cell Biol. 2005;6: 519–529. doi: 10.1038/nrm1684 [DOI] [PubMed] [Google Scholar]
  • 59.Matveeva EA, He P, Whiteheart SW. N-ethylmaleimide-sensitive fusion protein contains high and low affinity ATP-binding sites that are functionally distinct. J Biol Chem. 1997;272: 26413–26418. doi: 10.1074/jbc.272.42.26413 [DOI] [PubMed] [Google Scholar]
  • 60.Babst M, Wendland B, Estepa EJ, Emr SD. The Vps4p AAA ATPase regulates membrane association of a Vps protein complex required for normal endosome function. EMBO J. 1998;17: 2982–2993. doi: 10.1093/emboj/17.11.2982 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Corona DF, Längst G, Clapier CR, Bonte EJ, Ferrari S, Tamkun JW, et al. ISWI is an ATP-dependent nucleosome remodeling factor. Mol Cell. 1999;3: 239–245. doi: 10.1016/s1097-2765(00)80314-7 [DOI] [PubMed] [Google Scholar]
  • 62.Weibezahn J, Schlieker C, Bukau B, Mogk A. Characterization of a trap mutant of the AAA+ chaperone ClpB. J Biol Chem. 2003;278: 32608–32617. doi: 10.1074/jbc.M303653200 [DOI] [PubMed] [Google Scholar]
  • 63.Dalal S, Rosser MF, Cyr DM, Hanson PI. Distinct roles for the AAA ATPases NSF and p97 in the secretory pathway. Mol Biol Cell. 2004;15: 637–648. doi: 10.1091/mbc.e03-02-0097 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Zierhut C, Diffley JF. Break dosage, cell cycle stage and DNA replication influence DNA double strand break response. EMBO J. 2008;27: 1875–1885. doi: 10.1038/emboj.2008.111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Lisby M, Barlow JH, Burgess RC, Rothstein R. Choreography of the DNA damage response: spatiotemporal relationships among checkpoint and repair proteins. Cell. 2004;118: 699–713. doi: 10.1016/j.cell.2004.08.015 [DOI] [PubMed] [Google Scholar]
  • 66.Shim EY, Chung WH, Nicolette ML, Zhang Y, Davis M, Zhu Z, et al. Saccharomyces cerevisiae Mre11/Rad50/Xrs2 and Ku proteins regulate association of Exo1 and Dna2 with DNA breaks. EMBO J. 2010;29: 3370–3380. doi: 10.1038/emboj.2010.219 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Fishman-Lobell J, Rudin N, Haber JE. Two alternative pathways of double-strand break repair that are kinetically separable and independently modulated. Mol Cell Biol. 1992;12: 1292–1303. doi: 10.1128/mcb.12.3.1292-1303.1992 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Vaze MB, Pellicioli A, Lee SE, Ira G, Liberi G, Arbel-Eden A, et al. Recovery from checkpoint-mediated arrest after repair of a double-strand break requires Srs2 helicase. Mol Cell. 2002;10: 373–385. doi: 10.1016/s1097-2765(02)00593-2 [DOI] [PubMed] [Google Scholar]
  • 69.Ivanov EL, Sugawara N, Fishman-Lobell J, Haber JE. Genetic requirements for the single-strand annealing pathway of double-strand break repair in Saccharomyces cerevisiae. Genetics. 1996;142: 693–704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Strathern JN, Klar AJ, Hicks JB, Abraham JA, Ivy JM, Nasmyth KA, et al. Homothallic switching of yeast mating type cassettes is initiated by a double-stranded cut in the MAT locus. Cell. 1982;31: 183–192. doi: 10.1016/0092-8674(82)90418-4 [DOI] [PubMed] [Google Scholar]
  • 71.Ferguson DO, Holloman WK. Recombinational repair of gaps in DNA is asymmetric in Ustilago maydis and can be explained by a migrating D-loop model. Proc Natl Acad Sci USA. 1996;93: 5419–5424. doi: 10.1073/pnas.93.11.5419 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Saponaro M, Callahan D, Zheng X, Krejci L, Haber JE, Klein HL, et al. Cdk1 targets Srs2 to complete synthesis-dependent strand annealing and to promote recombinational repair. PLoS Genet. 2010;6: e1000858. doi: 10.1371/journal.pgen.1000858 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Prakash R, Satory D, Dray E, Papusha A, Scheller J, Kramer W, et al. Yeast Mph1 helicase dissociates Rad51-made D-loops: implications for crossover control in mitotic recombination. Genes Dev. 2009;23: 67–79. doi: 10.1101/gad.1737809 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Cassani C, Gobbini E, Wang W, Niu H, Clerici M, Sung P, et al. Tel1 and Rif2 regulate MRX functions in end-tethering and repair of DNA double-strand breaks. PLoS Biol. 2016;14: e1002387. doi: 10.1371/journal.pbio.1002387 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Chung WH, Zhu Z, Papusha A, Malkova A, Ira G. Defective resection at DNA double-strand breaks leads to de novo telomere formation and enhances gene targeting. PLoS Genet. 2010;6: e1000948. doi: 10.1371/journal.pgen.1000948 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Westmoreland JW, Resnick MA. Recombinational repair of radiation-induced double-strand breaks occurs in the absence of extensive resection. Nucleic Acids Res. 2016;44: 695–704. doi: 10.1093/nar/gkv1109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Guo X, Hum YF, Lehner K, Jinks-Robertson S. Regulation of hetDNA length during mitotic double-strand break repair in yeast. Mol Cell. 2017; 67: 539–549.e4. doi: 10.1016/j.molcel.2017.07.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Hailemariam S, Kumar S, Burgers PM. Activation of Tel1ATM kinase requires Rad50 ATPase and long nucleosome-free DNA but no DNA ends. J Biol Chem. 2019;294: 10120–10130. doi: 10.1074/jbc.RA119.008410 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Myler LR, Gallardo IF, Soniat MM, Deshpande RA, Gonzalez XB, Kim Y, et al. Single-molecule imaging reveals how Mre11-Rad50-Nbs1 initiates DNA break repair. Mol Cell. 2017;67: 891–898.e4. doi: 10.1016/j.molcel.2017.08.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.You Z, Shi LZ, Zhu Q, Wu P, Zhang YW, Basilio A, et al. CtIP links DNA double-strand break sensing to resection. Mol Cell. 2009;36: 954–969. doi: 10.1016/j.molcel.2009.12.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Limbo O, Chahwan C, Yamada Y, de Bruin RA, Wittenberg C, Russell P. Ctp1 is a cell-cycle-regulated protein that functions with Mre11 complex to control double-strand break repair by homologous recombination. Mol Cell. 2007;28: 134–146. doi: 10.1016/j.molcel.2007.09.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Williams RS, Dodson GE, Limbo O, Yamada Y, Williams JS, Guenther G, et al. Nbs1 flexibly tethers Ctp1 and Mre11-Rad50 to coordinate DNA double-strand break processing and repair. Cell. 2009;139: 87–99. doi: 10.1016/j.cell.2009.07.033 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Casari E, Gobbini E, Clerici M, Longhese MP. Resection of a DNA double-strand break by alkaline gel electrophoresis and Southern blotting. Methods Mol Biol. 2021;2153: 33–45. doi: 10.1007/978-1-0716-0644-5_3 [DOI] [PubMed] [Google Scholar]
  • 84.Trovesi C, Falcettoni M, Lucchini G, Clerici M, Longhese MP. Distinct Cdk1 requirements during single-strand annealing, noncrossover, and crossover recombination. PLoS Genet. 2011;7: e1002263.doi: 10.1371/journal.pgen.1002263 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Gregory P Copenhaver, Sue Jinks-Robertson

24 May 2021

Dear Dr Longhese,

Thank you very much for submitting your Research Article entitled 'The chromatin remodeler Chd1 supports the MRX complex in resection of DNA double-strand breaks' to PLOS Genetics. The manuscript was fully evaluated at the editorial level and by three independent peer reviewers. The reviewers appreciated the attention to an important problem, but raised concerns about the current manuscript that need to be addressed. For example, survival data following DSB induction needs to be included and there was an issue raised with regard to data normalization. In addition, the current work needs to be put in the context of what is know about the roles of other chromatin remodelers during DSB repair. Based on the reviews, we will not be able to accept this version of the manuscript, but we would be willing to review a much-revised version. We cannot, of course, promise publication at that time.

Should you decide to revise the manuscript for further consideration here, your revisions should address the specific points made by each reviewer. We will also require a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

If you decide to revise the manuscript for further consideration at PLOS Genetics, please aim to resubmit within the next 60 days, unless it will take extra time to address the concerns of the reviewers, in which case we would appreciate an expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments are included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool.  PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, use the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

We are sorry that we cannot be more positive about your manuscript at this stage. Please do not hesitate to contact us if you have any concerns or questions.

Yours sincerely,

Sue Jinks-Robertson, Ph.D.

Associate Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: review attached

Reviewer #2: The authors document that Chd1 has a role in resection of DSB ends and in promoting efficient repair of DSBs. Chd1 is shown to promote MRX binding to DSB ends. Chd1 likely works in the same pathway with MRX as deletion of CHD1 increases the sensitivity of rad50VM mutant (decreased association with DSB) but not with complete deletion of rad50. Finally, Chd1 is shown to help in nucleosome eviction at DSB ends. Together the manuscript presents interesting set of observations, however the authors need to provide additional evidence to support their conclusions.

Comments

Is the effect Chd1 deletion on resection direct or indirect? As chd1 is a chromatin remodeler it is possible that it regulates protein levels of MRX or other resection enzymes. Is Chd1 recruited to DSBs as would be expected if it played a direct role? What is the evidence for direct involvement of Chd1 in resection? Are Mre11, Rad50, and Xrs2 levels and localization similar in wild type and chd1? Genetics indicates that Chd1 works in the same pathway with MRX so at least one could test few things related to MRX levels and localization.

It looks that mostly initial resection is impacted in chd1 mutants. Authors should comment on this and test whether Chd1 affects also extensive resection.

Page 7

Please specify that chd1 cells are only "mildly" sensitive to "high" doses DNA damage inducing agents. In lower doses there is no sensitivity (Fig 6c).

Page 8-9 “Chd1 promotes DSB repair”

Viability of wt and chd1 cells (tested by plating on YEPGAL plates) in response to DSB needs to be shown for both SSA and ectopic recombination assays to conclude that Chd1 promotes DSB repair. What is shown is only kinetics of repair in nocodazole blocked cells, not the final repair. chd1 mutants are barely sensitive to DNA damaging agents therefore it is surprising that Chd1 is important for the repair of a single DSB. Are chd1 cells sensitive to zeocin, bleomycin or phleomycin?

In case resection was analyzed in nocodazole blocked cells, at least one set of experiments should be done in growing cells.

Comparison of the sensitivity of chd1, rad50 and double mutant in Figure 5D need to be shown across broad range of drugs concentration to support epistasis.

Other comments

Page 11

Chd1 promotes MRX but not Ku recruitment. Authors conclude that it is consistent

with the role of Chd1 in HR and not NHEJ. This should be rephrased as MRX is needed for NHEJ in budding yeast.

Previously it was reported that Chd1 deficient cells have normal resection PMID: 22960743. This was tested in the same strain background and no decrease of initial or extensive resection was observed. What is the reasons of these different observations? Were the cells arrested here in nocodazole? Methods section directs the reader to a manuscript that potentially indicates G2/M nocodazole arrest. If so it would be important to perform one experiment in growing cells (to exclude unlikely possibility that the effect of CHD1 deletion is specific to G2/M arrested cells). In general it should be indicated whether resection was analyzed in nocodazole blocked cells.

Reviewer #3: This is a generally clear and careful study of the role of the chromatin remodeler Chd1 in resection of DSBs in yeast. The overall conclusions seem justified, but there are a few places where the paper would benefit from further clarification.

1. The authors conclude that Chd1 plays some role in promoting the association of MRX with DSB ends. Wouldn’t the same results be obtained if the function of Chd1 was to stabilize its association or prevent its removal? Is there a way to see how long MRX says associated with a DSB?

2. I always admire the clear denaturing gels published by this lab! However, when I look at the results, it seems to me that r1 (1.7 kb) in the mutants is not that different from WT, suggesting to me that longer-range resection is more affected? So maybe a ChIP or Rad51 at a greater distance would be useful? More on resection below.

3. It would be useful in Figs. 1, 2 and 3 to compare these results to mre11∆ or rad50∆ and sae2∆. Is the effect of chd1∆ much less? My impression from Symington or Haber is that deleting MRX delays but doesn’t much reduce HR and even SSA over short distances. For example, Mimitou and Symington’s 2008 SSA results with sae2∆ (Fig. 1) shows a 65% efficiency but little change in kinetics.

4. Why a semi-log plot in Fig. 4?

5. In the absence of Mre11 or Rad50, is Sae2 ChIP affected? How is Sae2 recruited if not through MRX?

6. Again, is chd1∆ rad50-VM less severe than deleting Rad50?

7. Finally, Chd1 has been implicated in late recombinational steps in meiosis by Matos (i.e. in crossovers). There, Chd1 showed meiosis-specific MutSgamma-Exo1 interactions. These data aren’t discussed, but they raise the possibility that Exo1 might be involved in Chd1’s association mitotically as well.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Attachment

Submitted filename: plos gen longhese 2.docx

Decision Letter 1

Gregory P Copenhaver, Sue Jinks-Robertson

16 Aug 2021

Dear Dr Longhese,

Thank you very much for submitting your revised Research Article entitled 'The chromatin remodeler Chd1 supports MRX and Exo1 functions in resection of DNA double-strand breaks' to PLOS Genetics. The original three reviewers appreciated the care taken in revising the manuscript and were uniformly positive about the changes. Although there remain a few minor comments that need to be addressed (all editorial in nature), subsequent re-reveiw will not required.  Once you upload a revised version, I'll be happy to accept it.  

In addition we ask that you:

1) Briefly summarize your responses to the review comments and a description of the changes you have made in the manuscript.

2) Upload a Striking Image with a corresponding caption to accompany your manuscript if one is available (either a new image or an existing one from within your manuscript). If this image is judged to be suitable, it may be featured on our website. Images should ideally be high resolution, eye-catching, single panel square images. For examples, please browse our archive. If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License. Note: we cannot publish copyrighted images.

We hope to receive your revised manuscript within the next 30 days. If you anticipate any delay in its return, we would ask you to let us know the expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments should be included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, you will need to go to the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

Please let us know if you have any questions while making these revisions.

Yours sincerely,

Sue Jinks-Robertson, Ph.D.

Associate Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: The article is much improved and the authors took great care to address all the reviewers' comments. THis is greatly appreciated. It was useful and wise to move the data that was hard to interpret to supplemental material and to focus on the data that make sense. The ssDNA at close distances was important to provide.

I have only minor corrections to suggest:

line 74: Fun30 is not really very close to the INO80 family, which is characterized by a split ATPase domain. SWR1 and INO80 both have the split ATPase but Fun30 does not. It is true that Flaus et al. NAR 2006, and Seeber at al 2013 both place Fun30 in the INO80 family based on overall sequence homology, but I think line 74 should be phrased slightly differently: "... Fun30 (SMARCAD1 in mammals) has highest sequence homology to INO80-like remodelers but lacks the split ATPase domain."

line 161 "does not allow one to "

line 184 and elsewhere: " While MRC and Sae2 association to..." Should be either "binding to" or "association with" not as written. This error is made multiple times (see also line 195)

line 193: "contained similar amounts...."

line 312: "Chd1 was found to interact with Exo1 and to enable..." not "to interacts"

The rest is clear and worthy of publication in PLOS Genetics. A very nice paper.

Reviewer #2: The authors performed a number of additional experiments and addressed most of the questions raised by reviewers. Thus my opinion is to accepts revised manuscript.

Reviewer #3: The authors have made a substantial effort to address the concerns of the reviewers. I have only a few minor comments/suggestions:

1. Define the primers and restriction sites used to determine cutting efficiency. I didn’t find them in the text.

2. Whether Chd1 is really involved in histone eviction may depend on your definition. Pfander’s recent paper (Peritore et al. 2021) argues persuasively that there is no histone occupancy on ssDNA. So one might argue that monitoring histone loss is no different from monitoring resection. Other papers do suggest that histones are evicted prior to resection (most recently Tipuraneni et al. 2021, but earlier papers by Sang Lee and Mary Anne Osley). I think to really demonstrate that Chd1 is evicting histones would require that the histone removal be more extensive than the resection and that this difference would go away when Chd1 were absent.

3. One other thing that seems confusing to me: why does SSA not continue to increase beyond 180 min in Fig. 4? If resection is slower but there is more time, should SSA “catch up”? Why is viability lower if there is plenty of time for a viable colony-forming unit to be created? Looking at the HO-cut bands in Fig. 4B, it seems that resection is continuing between 180 and 240 min, but product formation doesn’t increase. This is strange.

4. Fig. 5 shows that deleting Chd1 didn’t affect the crossovers associated with the ectopic recombination strain tGI354. Although the Wild et al. (Matos lab) paper is now cited, the fact that Wild et al. already came to the same conclusion about crossovers in mitotic cells is not acknowledged.

5. At least mention the alternative suggestion that Chd1 might act to stabilize MRX association to DSBs rather than promote its recruitment. (One might tell the difference by using an AID mutant to inactivate Chd1 after recruitment of MRX had occurred; but I am not suggesting this experiment needs to be done).

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes: James E. Haber

Decision Letter 2

Gregory P Copenhaver, Sue Jinks-Robertson

6 Sep 2021

Dear Dr Longhese,

We are pleased to inform you that your manuscript entitled "The chromatin remodeler Chd1 supports MRX and Exo1 functions in resection of DNA double-strand breaks" has been editorially accepted for publication in PLOS Genetics. Congratulations!

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Sue Jinks-Robertson, Ph.D.

Associate Editor

PLOS Genetics

Gregory P. Copenhaver

Editor-in-Chief

PLOS Genetics

www.plosgenetics.org

Twitter: @PLOSGenetics

----------------------------------------------------

Comments from the reviewers (if applicable):

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website.

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: 

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-21-00513R2

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org.

Acceptance letter

Gregory P Copenhaver, Sue Jinks-Robertson

9 Sep 2021

PGENETICS-D-21-00513R2

The chromatin remodeler Chd1 supports MRX and Exo1 functions in resection of DNA double-strand breaks

Dear Dr Longhese,

We are pleased to inform you that your manuscript entitled "The chromatin remodeler Chd1 supports MRX and Exo1 functions in resection of DNA double-strand breaks" has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Katalin Szabo

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. List of yeast strains used in this study.

    (DOCX)

    S2 Table. List of oligonucleotides used in this study.

    (DOCX)

    S1 Fig. DSB resection.

    YEPR exponentially growing cell cultures of JKM139 derivative strains were transferred to YEPRG at time zero. Southern blot analysis of SspI-digested genomic DNA after alkaline gel electrophoresis with a probe that anneals to the unresected strand. 5’-3’ resection progressively eliminates SspI sites (S), producing SspI fragments (r1 through r6) detected by the probe.

    (TIF)

    S2 Fig. DNA damage sensitivity of chd1 mutants.

    Exponentially growing cultures were serially diluted (1:10) and each dilution was spotted out onto YEPD plates with or without CPT, MMS or phleomycin.

    (TIF)

    S1 Data. Original data sheets.

    (XLSX)

    Attachment

    Submitted filename: plos gen longhese 2.docx

    Attachment

    Submitted filename: Response to reviewers.docx

    Attachment

    Submitted filename: Response to reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS Genetics are provided here courtesy of PLOS

    RESOURCES